RENAL ALLOGRAFT RECIPIENTS
Clinical trials for RENAL ALLOGRAFT RECIPIENTS explained in plain language.
Never miss a new study
Get alerted when new RENAL ALLOGRAFT RECIPIENTS trials appear
Sign up with your email to follow new studies for RENAL ALLOGRAFT RECIPIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Teen kidney transplant patients may get a better drug option
Disease control Recruiting nowThis study tests whether switching teen kidney transplant recipients (ages 12-17) from standard immunosuppressants (calcineurin inhibitors) to belatacept (Nulojix) can improve kidney function and medication adherence. About 102 teens who received a kidney transplant at least 6 mo…
Matched conditions: RENAL ALLOGRAFT RECIPIENTS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New MRI scan could spare kidney transplant patients painful biopsies
Diagnosis Recruiting nowThis study is testing whether advanced, non-contrast MRI scans can safely and accurately monitor the health of transplanted kidneys. Currently, doctors rely on blood tests and invasive biopsies, which can miss early signs of trouble. Researchers will scan 1000 participants, inclu…
Matched conditions: RENAL ALLOGRAFT RECIPIENTS
Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC